MANCINI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 567
EU - Europa 352
AS - Asia 126
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.048
Nazione #
US - Stati Uniti d'America 565
IE - Irlanda 126
CN - Cina 79
DE - Germania 62
SE - Svezia 43
IT - Italia 42
TR - Turchia 24
UA - Ucraina 24
GB - Regno Unito 22
SG - Singapore 12
BE - Belgio 8
FI - Finlandia 8
CZ - Repubblica Ceca 6
ES - Italia 4
FR - Francia 4
IN - India 4
CA - Canada 2
EU - Europa 2
JP - Giappone 2
VN - Vietnam 2
BG - Bulgaria 1
IL - Israele 1
LB - Libano 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
TH - Thailandia 1
Totale 1.048
Città #
Chandler 143
Dublin 126
Jacksonville 101
Ann Arbor 35
Boardman 29
New York 23
Nanjing 21
L'aquila 20
Wilmington 19
Ashburn 18
Bremen 16
Izmir 16
Lawrence 16
Princeton 16
Woodbridge 15
Beijing 12
Grafing 11
San Mateo 11
Singapore 10
Brussels 8
Munich 7
Houston 6
Nanchang 6
Shenyang 6
Brno 5
Des Moines 5
Jinan 5
Seattle 5
Tianjin 5
Changsha 4
Dearborn 4
Falls Church 4
Kunming 4
Hanover 3
Hebei 3
Madrid 3
Norwalk 3
Shanghai 3
Washington 3
Berlin 2
Dallas 2
Dong Ket 2
Frankfurt am Main 2
Piombino Dese 2
Rome 2
Tokyo 2
Verona 2
Beauharnois 1
Beirut 1
Belgrade 1
Bologna 1
Carlentini 1
Casoria 1
Changchun 1
Fremont 1
Fuzhou 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Jiaxing 1
Lampang 1
Los Angeles 1
L’Aquila 1
Milan 1
Mountain View 1
Newark 1
Ningbo 1
Pavia 1
Phoenix 1
Pune 1
Santiago De Compostela 1
Shreveport 1
Sofia 1
Stockholm 1
Tappahannock 1
Toronto 1
Warsaw 1
Totale 796
Nome #
The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma 95
Prevention of chemotherapy-induced gonadotoxicity in the mouse model: protective effects of natural bioactive compounds 94
Crocetin and crocin from saffron in cancer chemotherapy and chemoprevention 80
Possible involvement of SIRT1 and FOXO3a in oxidative stress response and aging of human granulosa cells 77
EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO 77
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 77
UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 68
Possible role or SIRT 1in human ovarian granulosa cells 67
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 67
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models 66
Correction: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma (Journal of Hematology and Oncology (2018) 11(32) DOI: 10.1186/s13045-018-0576-6) 57
Fertility preservation in cancer patients: attenuation of chemotherapy-induced ovarian damage by oral administration of phytochemical carotenoids in an animal model. 55
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma (Journal of Cancer Research and Clinical Oncology, (2019), 145, 2, (393-409), 10.1007/s00432-018-2800-8) 55
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 46
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 36
Crocetin extracted from saffron shows antitumor effects in models of human glioblastoma 36
Prodrugs of Pyrazolo[3,4-d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model 30
Totale 1.083
Categoria #
all - tutte 4.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020102 0 0 14 4 3 17 20 4 16 9 1 14
2020/2021130 3 13 3 17 14 5 16 3 16 7 25 8
2021/2022117 7 1 16 8 5 14 4 5 11 10 8 28
2022/2023387 22 34 3 56 34 34 0 29 150 4 9 12
2023/202498 14 2 6 7 12 36 0 4 0 1 3 13
2024/202538 10 6 22 0 0 0 0 0 0 0 0 0
Totale 1.083